Joint (JYNT) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Joint Revenue Highlights


Latest Revenue (Y)

$54.90M

Latest Revenue (Q)

$14.82M

Main Segment (Y)

Royalty

Joint Revenue by Period


Joint Revenue by Year

DateRevenueChange
2025-12-31$54.90M5.24%
2024-12-31$52.16M11.04%
2023-12-31$46.98M-53.60%
2022-12-31$101.25M26.55%
2021-12-31$80.01M36.34%
2020-12-31$58.68M21.12%
2019-12-31$48.45M52.41%
2018-12-31$31.79M26.33%
2017-12-31$25.16M22.61%
2016-12-31$20.52M48.34%
2015-12-31$13.84M94.41%
2014-12-31$7.12M19.45%
2013-12-31$5.96M113.94%
2012-12-31$2.78M-

Joint generated $54.90M in revenue during NA 2025, up 5.24% compared to the previous quarter, and up 93.55% compared to the same period a year ago.

Joint Revenue by Quarter

DateRevenueChange
2026-03-31$14.82M-2.29%
2025-12-31$15.17M13.35%
2025-09-30$13.38M0.83%
2025-06-30$13.27M1.47%
2025-03-31$13.08M-134.16%
2024-12-31$-38.28M-226.78%
2024-09-30$30.20M139.48%
2024-06-30$12.61M3.49%
2024-03-31$12.18M-60.20%
2023-12-31$30.61M3.87%
2023-09-30$29.47M0.57%
2023-06-30$29.31M3.56%
2023-03-31$28.30M1.76%
2022-12-31$27.81M5.15%
2022-09-30$26.45M6.28%
2022-06-30$24.89M11.92%
2022-03-31$22.24M0.61%
2021-12-31$22.10M5.29%
2021-09-30$20.99M3.82%
2021-06-30$20.22M15.22%
2021-03-31$17.55M2.99%
2020-12-31$17.04M10.56%
2020-09-30$15.41M22.41%
2020-06-30$12.59M-7.73%
2020-03-31$13.64M-1.66%
2019-12-31$13.88M9.03%
2019-09-30$12.73M13.93%
2019-06-30$11.17M4.59%
2019-03-31$10.68M17.72%
2018-12-31$9.07M12.52%
2018-09-30$8.06M6.69%
2018-06-30$7.56M6.47%
2018-03-31$7.10M2.43%
2017-12-31$6.93M5.86%
2017-09-30$6.55M8.83%
2017-06-30$6.01M6.01%
2017-03-31$5.67M-1.85%
2016-12-31$5.78M5.04%
2016-09-30$5.50M10.65%
2016-06-30$4.97M16.62%
2016-03-31$4.27M13.35%
2015-12-31$3.76M-9.07%
2015-09-30$4.14M20.76%
2015-06-30$3.43M36.64%
2015-03-31$2.51M22.02%
2014-12-31$2.06M13.15%
2014-09-30$1.82M4.89%
2014-06-30$1.73M14.48%
2014-03-31$1.51M-8.45%
2013-12-31$1.65M12.20%
2013-09-30$1.47M-

Joint generated $14.82M in revenue during Q1 2026, up -2.29% compared to the previous quarter, and up -38.71% compared to the same period a year ago.

Joint Revenue Breakdown


Joint Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 25Dec 24Dec 23Dec 22Dec 21
Product and Service, Other$1.83M$1.89M$1.53M$1.45M$1.26M
Advertising$10.45M$9.18M$8.32M$7.46M$6.30M
Franchise$3.37M$3.00M$2.88M$2.44M$2.66M
Technology Service$6.04M$5.69M$5.09M$4.29M$3.38M
Royalty$33.20M$32.14M$29.16M$26.19M$22.06M
Revenues and Management Fees from Company Clinics--$70.72M$59.42M$44.35M
Regional Developer Fees---$659.10K$848.64K

Joint's latest annual revenue breakdown by segment (product or service), as of Dec 25: Royalty (60.49%), Advertising (19.04%), Technology Service (11.00%), Franchise (6.14%), and Product and Service, Other (3.34%).

Quarterly Revenue by Product

Product/ServiceMar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21
Technology Service$1.53M$1.55M$1.55M$1.48M$1.46M$2.87M$1.43M$1.39M$1.34M$1.30M$1.23M$1.21M$1.12M$1.11M$1.10M$957.00K$996.31K$840.97K$786.04K$760.54K
Advertising$3.65M$3.47M$2.34M$2.33M$2.31M$4.77M$2.25M$2.17M$2.28M$2.05M$2.04M$1.95M$2.04M$1.88M$1.83M$1.71M$1.78M$1.63M$1.52M$1.37M
Franchise$1.15M$810.09K$964.80K$768.10K$828.52K$344.72K$2.00M$655.87K$703.07K$754.03K$671.37K$754.42K$471.07K$642.40K$686.89K$640.97K$691.42K$648.60K$623.65K$695.43K
Product and Service, Other$460.89K$449.42K$418.81K$554.69K$408.62K$1.09M$407.13K$387.99K$409.04K$342.14K$384.96K$390.00K$392.72K$375.31K$370.56K$312.14K$372.58K$316.06K$310.07K$259.20K
Royalty$8.03M$8.89M$8.11M$8.13M$8.07M$16.69M$7.87M$7.59M$7.98M$7.14M$7.17M$6.87M$7.17M$6.60M$6.41M$6.01M$6.25M$5.71M$5.33M$4.77M
Revenues and Management Fees from Company Clinics------$17.54M$17.54M$17.91M$17.88M$17.80M$17.13M$16.49M$15.84M$14.49M$12.61M$11.81M$11.63M$11.43M$9.47M
Regional Developer Fees-----------$149.48K$134.18K$153.18K$169.95K$201.79K$206.60K$209.65K$214.43K$217.96K

Joint's latest quarterly revenue breakdown by segment (product or service), as of Mar 26: Royalty (54.20%), Advertising (24.61%), Technology Service (10.36%), Franchise (7.73%), and Product and Service, Other (3.11%).

Joint Revenue Breakdown by Country

Quarterly Revenue by Country

CountryMar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Dec 18Sep 18Jun 18
Franchise$754.42K$471.07K$642.40K$686.89K$640.97K$691.42K$648.60K$623.65K$695.43K$544.95K$519.13K$523.96K$512.75K$385.87K$541.34K$447.27K$433.04K$457.52K$449.14K-
Royalty$6.87M$7.17M$6.60M$6.41M$6.01M$6.25M$5.71M$5.33M$4.77M$4.73M$4.17M$3.27M$3.72M$3.82M$3.45M$3.26M$2.59M$2.42M--
Regional Developer Fees$149.48K$134.18K$153.18K$169.95K$201.79K$206.60K$209.65K$214.43K$217.96K$232.83K$222.91K$213.42K$207.64K$209.23K$210.23K$200.52K$184.29K$142.65K$137.41K-
Revenues and Management Fees from Company Clinics$17.13M$16.49M$15.84M$14.49M$12.61M$11.81M$11.63M$11.43M$9.47M$9.22M$8.40M$6.86M$7.29M$7.56M$6.83M$5.78M$5.64M$3.67M$3.42M-
Advertising$1.95M$2.04M$1.88M$1.83M$1.71M$1.78M$1.63M$1.52M$1.37M$1.33M$1.19M$930.79K$1.06M$1.09M$978.21K$927.80K$736.99K$687.75K--
Product and Service, Other$390.00K$392.72K$375.31K$370.56K$312.14K$372.58K$316.06K$310.07K$259.20K$255.66K$218.27K$164.95K$208.22K$203.32K$205.40K$176.45K$137.78K$124.74K--
Technology Service$1.21M$1.12M$1.11M$1.10M$957.00K$996.31K$840.97K$786.04K$760.54K$729.55K$688.05K$631.20K$645.73K$609.07K$514.35K$377.13K$324.25K$315.91K--

Joint's latest quarterly revenue breakdown by geography, as of Mar 23: Revenues and Management Fees from Company Clinics (60.20%), Royalty (24.13%), Advertising (6.86%), Technology Service (4.25%), Franchise (2.65%), Product and Service, Other (1.37%), and Regional Developer Fees (0.53%).

Joint Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
DCGODocGo$322.20T$75.55T
LUCDLucid Diagnostics$4.71B$1.26B
BTMDbiote$192.22M$44.94M
CCLDCareCloud$120.50M$31.27M
JYNTJoint$54.90M$14.82M
APYXApyx Medical$52.10M$12.42M
RPIDRapid Micro Biosystems$33.59M$8.00M
STSSSkyAI$204.12K$192.78K
SERASera Prognostics$81.00K$17.00K
CGTXCognition Therapeutics--
IKTInhibikase Therapeutics--

JYNT Revenue FAQ


What is Joint’s yearly revenue?

Joint's yearly revenue for 2025 was $54.9M, representing an increase of 5.24% compared to 2024. The company's yearly revenue for 2024 was $52.16M, representing an increase of 11.04% compared to 2023. JYNT's yearly revenue for 2023 was $46.98M, representing a decrease of -53.60% compared to 2022.

What is Joint’s quarterly revenue?

Joint's quarterly revenue for Q1 2026 was $14.82M, a -2.29% decrease from the previous quarter (Q4 2025), and a 13.33% increase year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $15.17M, a 13.35% increase from the previous quarter (Q3 2025), and a 0% increase year-over-year (Q4 2024). JYNT's quarterly revenue for Q3 2025 was $13.38M, a 0.83% increase from the previous quarter (Q2 2025), and a -55.69% decrease year-over-year (Q3 2024).

What is Joint’s revenue growth rate?

Joint's revenue growth rate for the last 3 years (2023-2025) was 16.86%, and for the last 5 years (2021-2025) was -31.39%.

What are Joint’s revenue streams?

Joint's revenue streams in c 25 are Product and Service, Other, Advertising, Franchise, Technology Service, and Royalty. Product and Service, Other generated $1.83M in revenue, accounting 3.34% of the company's total revenue, down -2.91% year-over-year. Advertising generated $10.45M in revenue, accounting 19.04% of the company's total revenue, up 13.84% year-over-year. Franchise generated $3.37M in revenue, accounting 6.14% of the company's total revenue, up 12.46% year-over-year. Technology Service generated $6.04M in revenue, accounting 11.00% of the company's total revenue, up 6.16% year-over-year. Royalty generated $33.2M in revenue, accounting 60.49% of the company's total revenue, up 3.29% year-over-year.

What is Joint’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Joint was Royalty. This segment made a revenue of $33.2M, representing 60.49% of the company's total revenue.